Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.

about

18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways.

P2860

Q55406035-D611D76F-1EBE-4230-AC61-076325A4B705

P2860

Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.

Item

http://www.wikidata.org/entity/Q47732353

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Proteasome inhibitor bortezomi ...... adiation-induced osteoporosis.

@en

Proteasome inhibitor bortezomi ...... adiation-induced osteoporosis.

@nl

type

Item

label

Proteasome inhibitor bortezomi ...... adiation-induced osteoporosis.

@en

Proteasome inhibitor bortezomi ...... adiation-induced osteoporosis.

@nl

prefLabel

Proteasome inhibitor bortezomi ...... adiation-induced osteoporosis.

@en

Proteasome inhibitor bortezomi ...... adiation-induced osteoporosis.

@nl

P1476

Proteasome inhibitor bortezomi ...... adiation-induced osteoporosis.

@en

P2093

Abhishek Chandra

http://www.w3.org/2001/XMLSchema#string

Keith Cengel

http://www.w3.org/2001/XMLSchema#string

Leilei Zhong

http://www.w3.org/2001/XMLSchema#string

Ling Qin

http://www.w3.org/2001/XMLSchema#string

Luqiang Wang

http://www.w3.org/2001/XMLSchema#string

Michael A Levine

http://www.w3.org/2001/XMLSchema#string

Robert J Pignolo

http://www.w3.org/2001/XMLSchema#string

Tiffany Young

http://www.w3.org/2001/XMLSchema#string

Wei-Ju Tseng

http://www.w3.org/2001/XMLSchema#string

X Sherry Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond DNA repair: DNA-PK function in cancer

Insufficiency fracture after radiation therapy

Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination.

Emerging roles of caspase-3 in apoptosis

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

Valosin-containing protein regulates the proteasome-mediated degradation of DNA-PKcs in glioma cells.

Assessing new bone formation in neonatal calvarial organ cultures.

Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms.

Induction of cell death by radiotherapy.

The effects of proteasome inhibitors on bone remodeling in multiple myeloma.

P304

52-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.201700375R

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28860152

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

5731129

http://www.w3.org/2001/XMLSchema#string

Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.

about

P2860

P2860

Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932